- PMLiVE

Asking better questions to inform a stronger strategy

Pausing to question the data being used to inform decisions is invaluable in creating better strategy

- PMLiVE

Walking in their shoes

The impact of experiencing what it would be like to have a chronic disease for a day

- PMLiVE

Will that be cash or charge?

India is asking people to pay for booster shots, but extremely poor countries should never consider charging people for public health services

- PMLiVE

Eli Lilly and Incyte’s Olumiant receives FDA approval for alopecia

The treatment is the first and only systemic medicine for adults with the condition

- PMLiVE

Lessons from a pandemic – holistic strategy in the time of coronavirus

COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge

- PMLiVE

bluebird bio maintains its focus on gene therapy opportunities during structural changes

The company plans to reduce its workforce amid efforts to reduce its operating costs

- PMLiVE

2022 PM Society Awards

The 36th annual awards was held at the Grosvenor House Hotel in London

- PMLiVE

Sanofi unveils new corporate brand and logo

Sanofi Pasteur and Sanofi Genzyme will unite under the new brand image

- PMLiVE

Pfizer and BioNTech start clinical trial for Omicron-based COVID-19 vaccine

The clinical trial involves adults aged 18 to 55 who received an Omicron-based vaccine candidate as part of a two-dose primary series, as well as a booster

- PMLiVE

Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events

With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay

- PMLiVE

Almirall and IRB Barcelona announce new research collaboration

The two companies will work together to discover new therapies for chronic skin diseases